Trinity Biotech Plc (TRIB)
5.69
-0.63
(-9.97%)
USD |
NASDAQ |
Oct 02, 16:00
5.46
-0.23
(-4.04%)
After-Hours: 20:00
Trinity Biotech Net Income (Quarterly) : -4.416M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -4.416M |
| December 31, 2025 | -17.46M |
| September 30, 2025 | -5.112M |
| June 30, 2025 | -6.047M |
| March 31, 2025 | -8.804M |
| December 31, 2024 | -16.27M |
| September 30, 2024 | -4.759M |
| June 30, 2024 | -6.757M |
| March 31, 2024 | -3.317M |
| December 31, 2023 | -5.502M |
| September 30, 2023 | -6.72M |
| June 30, 2023 | -18.35M |
| March 31, 2023 | -6.305M |
| December 31, 2022 | -10.50M |
| September 30, 2022 | -9.932M |
| June 30, 2022 | -10.04M |
| March 31, 2022 | -2.003M |
| December 31, 2021 | 1.52M |
| September 30, 2021 | 1.35M |
| June 30, 2021 | 5.285M |
| March 31, 2021 | 1.602M |
| December 31, 2020 | 7.752M |
| September 30, 2020 | 7.325M |
| June 30, 2020 | -1.467M |
| March 31, 2020 | 0.203M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.121M |
| September 30, 2019 | 0.025M |
| June 30, 2019 | -5.405M |
| March 31, 2019 | -0.211M |
| December 31, 2018 | 1.223M |
| September 30, 2018 | 0.896M |
| June 30, 2018 | 0.594M |
| March 31, 2018 | 0.378M |
| December 31, 2017 | 1.375M |
| September 30, 2017 | 0.445M |
| June 30, 2017 | 0.902M |
| March 31, 2017 | 1.246M |
| December 31, 2016 | 4.783M |
| September 30, 2016 | -0.517M |
| June 30, 2016 | 2.104M |
| March 31, 2016 | -1.347M |
| December 31, 2015 | 2.788M |
| September 30, 2015 | 11.86M |
| June 30, 2015 | 2.475M |
| March 31, 2015 | 3.55M |
| December 31, 2014 | 3.839M |
| September 30, 2014 | 4.248M |
| June 30, 2014 | 4.368M |
| March 31, 2014 | 4.516M |
| December 31, 2013 | 4.751M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -21.79M |
| Akari Therapeutics Plc | -4.816M |
| Autolus Therapeutics Plc | -39.18M |
| Evaxion AS | -3.724M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 10.84M |
| Total Expenses (Quarterly) | 15.26M |
| EPS Diluted (Quarterly) | -6.853 |
| Enterprise Value | 136.51M |
| Profit Margin (Quarterly) | -40.74% |
| Earnings Yield | -930.2% |